Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Gastroenterology|January 31, 2026
Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease SubtypesGi-Ae Kim, Heejoon Jang, Moon Young Kim, et al.Annals of Internal Medicine|September 16, 2024
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic ModelGi-Ae Kim, Young-Suk Lim, Seungbong Han, et al.Alimentary Pharmacology & Therapeutics|February 23, 2024
High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre studyJun Sik Yoon, Ji Hoon Hong, Soo Young Park, et al.Eclinicalmedicine|October 25, 2023
Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysisJong Woo Hahn, Hye Ran Yang, Jin Soo Moon, et al.Journal of Hepatology|December 22, 2024
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis BHyunjae Shin, Moon Haeng Hur, Byeong Geun Song, et al.The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.Gut|March 27, 2020
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyMinseok Albert Kim, Seung Up Kim, Dong Hyun Sinn, et al.Journal of Korean Medical Science|October 13, 2018
Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control StudySung-Eun Kim, Eun Sun Jang, Moran Ki, et al.Eclinicalmedicine|August 20, 2025
Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort studyRui Huang, Dae Won Jun, Hidenori Toyoda, et al.Clinical and Molecular Hepatology|March 17, 2025
Impact of components of metabolic syndrome on long-term outcomes of CHB with nucleos(t)ide analogue treatmentRui Huang, Dae Won Jun, Hidenori Toyoda, et al.Pageof 7